Patients with diabetes were no more likely to suffer infection, deep vein thrombosis (a deep vein blood clot) or other complications following total knee replacement (TKR) than patients without diabetes, according to new ...
Feb 27, 2013
0
0
After total knee replacement (TKR) surgery, patients who are morbidly obese have similar pain and function outcomes as patients who do not fall into this weight category, according to a new study by researchers at Hospital ...
Nov 11, 2012
0
0
Two new studies by researchers at Hospital for Special Surgery have overturned common beliefs about joint replacement in patients with lupus and rheumatoid arthritis (RA).
Nov 11, 2012
0
0
Patients who make $35,000 a year or less report better outcomes after knee replacement surgery than people who earn more, research by Mayo Clinic and the University of Alabama at Birmingham shows. The lower-income patients ...
Nov 10, 2012
0
0
Research from the Rothman Institute at Jefferson has shown aspirin to be just as effective as warfarin in preventing clots, specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the ...
Nov 8, 2012
0
0
Obese patients have a greater risk of complications following total knee replacement surgery, including post-surgical infections, according to a new literature review recently published in the Journal of Bone and Joint Surgery ...
Oct 24, 2012
0
0
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according ...
Sep 21, 2012
0
0
The clot-inhibiting drug apixaban (trade name: Eliquis) was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint. In an early benefit assessment pursuant to the ...
Sep 17, 2012
0
0
Patients who have had metal-on-metal hip replacements are no more likely to develop cancer in the first seven years after surgery than the general population, although a longer-term study is required, a study published in ...
Apr 3, 2012
0
0
(HealthDay) -- A U.S. Food and Drug Administration advisory panel on Monday will weigh the wisdom of allowing new clinical trials of a class of powerful painkillers for osteoarthritis. The drugs may have worked so well for ...
Mar 12, 2012
0
0
